Np mrd loader

Record Information
Version2.0
Created at2021-06-19 18:41:58 UTC
Updated at2025-02-13 00:03:31 UTC
NP-MRD IDNP0026938
Natural Product DOIhttps://doi.org/10.57994/3715
Secondary Accession NumbersNone
Natural Product Identification
Common NameSilvestrol
Provided ByJEOL DatabaseJEOL Logo
DescriptionSilvestrol is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Silvestrol is found in Aglaia foveolata and Aglaia silvestris. Silvestrol was first documented in 2021 (PMID: 34353608). Based on a literature review a small amount of articles have been published on silvestrol (PMID: 34104125) (PMID: 34058216) (PMID: 34001163).
Structure
Thumb
Synonyms
ValueSource
(-)-SilvestrolChEBI
Chemical FormulaC34H38O13
Average Mass654.6650 Da
Monoisotopic Mass654.23124 Da
IUPAC Namemethyl (2S,3R,4R,5S,6R)-10-{[(2S,3R,6R)-6-[(1R)-1,2-dihydroxyethyl]-3-methoxy-1,4-dioxan-2-yl]oxy}-2,3-dihydroxy-12-methoxy-6-(4-methoxyphenyl)-5-phenyl-7-oxatricyclo[6.4.0.0^{2,6}]dodeca-1(12),8,10-triene-4-carboxylate
Traditional Namemethyl (2S,3R,4R,5S,6R)-10-{[(2S,3R,6R)-6-[(1R)-1,2-dihydroxyethyl]-3-methoxy-1,4-dioxan-2-yl]oxy}-2,3-dihydroxy-12-methoxy-6-(4-methoxyphenyl)-5-phenyl-7-oxatricyclo[6.4.0.0^{2,6}]dodeca-1(12),8,10-triene-4-carboxylate
CAS Registry NumberNot Available
SMILES
[H]OC([H])([H])[C@@]([H])(O[H])[C@]1([H])O[C@@]([H])(OC2=C([H])C(OC([H])([H])[H])=C3C(O[C@@]4(C5=C([H])C([H])=C(OC([H])([H])[H])C([H])=C5[H])[C@]([H])(C5=C([H])C([H])=C([H])C([H])=C5[H])[C@@]([H])(C(=O)OC([H])([H])[H])[C@@]([H])(O[H])[C@@]34O[H])=C2[H])[C@]([H])(OC([H])([H])[H])OC1([H])[H]
InChI Identifier
InChI=1S/C34H38O13/c1-40-20-12-10-19(11-13-20)34-27(18-8-6-5-7-9-18)26(30(38)42-3)29(37)33(34,39)28-23(41-2)14-21(15-24(28)47-34)45-32-31(43-4)44-17-25(46-32)22(36)16-35/h5-15,22,25-27,29,31-32,35-37,39H,16-17H2,1-4H3/t22-,25-,26-,27-,29-,31-,32-,33+,34+/m1/s1
InChI KeyGVKXFVCXBFGBCD-QKDMMWSPSA-N
Experimental Spectra
Spectrum TypeDescriptionDepositor EmailDepositor OrganizationDepositorDeposition DateView
NOESY NMR[1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental)rakotondraibe.1@osu.eduThe Ohio State UniversityHarinantenaina Liva Rakotondraibe2025-02-11View Spectrum
COSY NMR[1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental)rakotondraibe.1@osu.eduThe Ohio State UniversityHarinantenaina Liva Rakotondraibe2025-02-11View Spectrum
HMBC NMR[1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental)rakotondraibe.1@osu.eduThe Ohio State UniversityHarinantenaina Liva Rakotondraibe2025-02-11View Spectrum
HSQC NMR[1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental)rakotondraibe.1@osu.eduThe Ohio State UniversityHarinantenaina Liva Rakotondraibe2025-02-11View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental)rakotondraibe.1@osu.eduThe Ohio State UniversityHarinantenaina Liva Rakotondraibe2025-02-11View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental)rakotondraibe.1@osu.eduThe Ohio State UniversityHarinantenaina Liva Rakotondraibe2025-02-11View Spectrum
1D NMR13C NMR Spectrum (1D, 500 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 100 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 200 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 300 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 400 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 600 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 700 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 800 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 900 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 1000 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Aglaia foveolataLOTUS Database
Aglaia perviridis
      Not Available
Aglaia silvestrisJEOL database
    • Hwang, B. Y., et al, J. Org. Chem. 69, 3350 (2004)
Aglaia sp.KNApSAcK Database
Chemical Taxonomy
ClassificationNot classified
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP2.26ALOGPS
logP1.97ChemAxon
logS-4.1ALOGPS
pKa (Strongest Acidic)11.61ChemAxon
pKa (Strongest Basic)-3ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count12ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area171.83 ŲChemAxon
Rotatable Bond Count11ChemAxon
Refractivity161.98 m³·mol⁻¹ChemAxon
Polarizability66.8 ųChemAxon
Number of Rings6ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDC00056124
Chemspider ID9961792
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkSilvestrol
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI ID66484
Good Scents IDNot Available
References
General References
  1. Nilewski C, Michels TD, Packard GK, Xiang AX, Sprengeler PA, Eam B, Fish S, Thompson PA, Wegerski CJ, Nevarez A, Clarine J, Sperry S, Ernst JT, Reich SH: 1-Aminomethyl SAR in a novel series of flavagline-inspired eIF4A inhibitors: Effects of amine substitution on cell potency and in vitro PK properties. Bioorg Med Chem Lett. 2021 Sep 1;47:128111. doi: 10.1016/j.bmcl.2021.128111. Epub 2021 Aug 2. [PubMed:34353608 ]
  2. Greger H: Comparative phytochemistry of flavaglines (= rocaglamides), a group of highly bioactive flavolignans from Aglaia species (Meliaceae). Phytochem Rev. 2021 Jun 4:1-40. doi: 10.1007/s11101-021-09761-5. [PubMed:34104125 ]
  3. Su ZH, Gao YH, Cheng S, Wen Y, Tang XD, Li MW, Wu YC, Wang XY: Identification of the in vitro antiviral effect of BmNedd2-like caspase in response to Bombyx mori nucleopolyhedrovirus infection. J Invertebr Pathol. 2021 Jul;183:107625. doi: 10.1016/j.jip.2021.107625. Epub 2021 May 29. [PubMed:34058216 ]
  4. Hashimoto A, Handa H, Hata S, Tsutaho A, Yoshida T, Hirano S, Hashimoto S, Sabe H: Inhibition of mutant KRAS-driven overexpression of ARF6 and MYC by an eIF4A inhibitor drug improves the effects of anti-PD-1 immunotherapy for pancreatic cancer. Cell Commun Signal. 2021 May 17;19(1):54. doi: 10.1186/s12964-021-00733-y. [PubMed:34001163 ]
  5. Hwang, B. Y., et al. (2004). Hwang, B. Y., et al, J. Org. Chem. 69, 3350 (2004). J. Org. Chem..